The treatment of breast cancer is daunting for patients and their families. This is because it requires multiple visits for chemotherapy and hospitalizations, in addition to being tiring and expensive. Recently, researchers have developed a new therapy that can be administered to patients at their homes. The USFDA has recently approved a combination of pertuzumab, trastuzumab, and hyaluronidase for treating adult patients with early as well as malignant human epidermal growth factor receptor 2 (HER2)-positive breast cancer.
The treatment is approved for administration under the skin in patients whose diagnosis has been confirmed based on an FDA-approved companion diagnostic test. According to the instructions, the therapy should first be administered in combination with chemotherapy, followed by subsequent administration at home. Currently, patients have to visit infusion centers for…
